C. Witmer

C. Witmer, T. Giglia, 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

The effects of alpha, beta-unsaturated aldehydes on hepatic thiols and thiol-containing enzymes.

C. Witmer, G. Witz, K. Cooper, 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

A Multicenter Cohort Study of Inferior Vena Cava Filter Use in Children

K. Glanz, C. Witmer, R. Shinohara, 2015, Pediatric blood & cancer.

Treatment of venous thromboembolism in pediatric patients.

C. Witmer, L. Raffini, 2020, Blood.

Interruption of the enterohepatic cirucaltion and its effect on rat bile.

C. Witmer, H. M. Vars, H. Light, 1959, The American journal of physiology.

Crossing the blood–brain barrier: clinical interactions between neurologists and hematologists in pediatrics – advances in childhood arterial ischemic stroke and cerebral venous thrombosis

R. Ichord, C. Witmer, 2010, Current opinion in pediatrics.

Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study

C. Kempton, P. Monahan, M. Ragni, 2015, Journal of thrombosis and haemostasis : JTH.

Pediatric transplantation: managing bleeding

C. Witmer, L. Raffini, 2015, Journal of thrombosis and haemostasis : JTH.

Spontaneous Subclavian Vein Thrombosis in a Healthy Adolescent Cheerleader: A Case of Paget-Schroetter Syndrome

C. Witmer, Andrew S Chu, J. Harkness, 2017, Pediatric emergency care.

Low mortality from intracranial haemorrhage in paediatric patients with haemophilia

C. Witmer, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effect.

J. Puetz, C. Witmer, L. Raffini, 2012, The Journal of pediatrics.

Bone marrow depressant and leukemogenic actions of benzene.

R. Snyder, C. Witmer, E. Lee, 1977, Life sciences.

Antithrombin Concentrate Use in Pediatric Extracorporeal Membrane Oxygenation: A Multicenter Cohort Study*

Samir S. Shah, C. Witmer, T. Brogan, 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States

C. Manno, C. Witmer, J. Soucie, 2011, British journal of haematology.

Organized sports participation and the association with injury in paediatric patients with haemophilia

C. Witmer, L. Raffini, S. McGee, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

The clinical management of hemophilia and head trauma: A survey of current clinical practice among pediatric hematology/oncology physicians

C. Manno, R. Butler, C. Witmer, 2009, Pediatric blood & cancer.

Hematologic manifestations of systemic disease (including iron deficiency, anemia of inflammation and DIC).

C. Witmer, 2013, The Pediatric clinics of North America.

Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Anticoagulation and Thrombolysis

C. Witmer, Jonathan W Byrnes, T. Giglia, 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Antithrombin concentrate use in children: a multicenter cohort study.

C. Witmer, T. Brogan, Samir S Shah, 2013, The Journal of pediatrics.

The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States

M. Recht, C. Witmer, P. Kouides, 2020, American journal of hematology.

Mycoplasma pneumoniae, Splenic Infarct, and Transient Antiphospholipid Antibodies: A New Association?

Samir S. Shah, A. Steenhoff, C. Witmer, 2007, Pediatrics.

Incidence of bleeding complications in pediatric patients with type 1 von Willebrand disease undergoing adenotonsillar procedures.

C. Manno, R. Butler, C. Witmer, 2009, The Journal of pediatrics.

Intracranial Hemorrhage in Patients with Hemophilia in the Prophylaxis Era.

C. Manno, C. Witmer, J. Soucie, 2008 .

Predictors of bleeding disorders in children with epistaxis: value of preoperative tests and clinical screening.

C. Witmer, L. Elden, M. Reinders, 2012, International journal of pediatric otorhinolaryngology.

Predictors of Bleeding Disorders in Children with Epistaxis: Value of Preoperative Tests and Clinical Screening

C. Witmer, L. Elden, M. Reinders, 2011 .

A prospective study of von Willebrand factor levels and bleeding in pregnant women with type 1 von Willebrand disease

B. Konkle, C. Witmer, A. Shapiro, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Validation Study of the Composite Score to Identify Von Willebrand Disease in Children

C. Moore, B. Kerlin, C. Witmer, 2013, Journal of pediatric hematology/oncology.

Management of Hemophilia and Head Trauma: A Survey of Current Clinical Practice among Pediatric Hematology/Oncology Physicians.

C. Manno, C. Witmer, L. Raffini, 2007 .

Mutagenicity and toxicity studies of several alpha,beta-unsaturated aldehydes in the Salmonella typhimurium mutagenicity assay.

C. Witmer, G. Witz, K. Cooper, 1987, Environmental mutagenesis.

Immune hemolytic anemia with drug‐induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma

Michael Fisher, M. Weiss, C. Witmer, 2014, Transfusion.

Cytochromes P-450 and b5

R. Snyder, C. Witmer, D. Cooper, 1975, Advances in Experimental Medicine and Biology.

Benzene metabolism in mouse liver microsomes.

R. Snyder, C. Witmer, J. Kocsis, 1973, Toxicology and applied pharmacology.

Biological Reactive Intermediates

D. Parke, R. Snyder, C. Witmer, 1977, Springer US.

Benzene Metabolism and Toxicity

Robert Snyder, R. Snyder, C. Witmer, 1977 .

Effects of endotoxin upon rat hepatic microsomal drug metabolism in vivo and in vitro.

B. Sonawane, C. Witmer, S. Yaffe, 1982, Xenobiotica; the fate of foreign compounds in biological systems.

Effects of toluene on the metabolism, disposition and hemopoietic toxicity of [3H]benzene.

R Snyder, R. Snyder, C. Witmer, 1977, Biochemical pharmacology.

Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk

C. Witmer, M. Lambert, Michele P. Lambert, 2018, Pediatric blood & cancer.

High mobility group proteins 1 and 2 recognize chromium-damaged DNA.

Jian Fei Wang, P. Billings, C. Witmer, 1997, Carcinogenesis.

Effects of a nonsteroidal anti-inflammatory agent and phenobarbital on hepatic microsomal mono-oxygenases in adjuvant disease in the rat.

C. Witmer, R. D. Smyth, P. Mathur, 1978, Biochemical pharmacology.

Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia

C. Witmer, M. Lambert, J. Kwiatkowski, 2017, American journal of hematology.

Dramatic Increase in Venous Thromboembolism in Children's Hospitals in the United States From 2001 to 2007

C. Feudtner, C. Witmer, L. Raffini, 2009, Pediatrics.

Extreme thrombocytosis is associated with critical illness and young age, but not increased thrombotic risk, in hospitalized pediatric patients

J. Flibotte, C. Witmer, M. Lambert, 2020, Journal of thrombosis and haemostasis : JTH.

The Effects of α,β-Unsaturated Aldehydes on Hepatic Thiols and Thiol-Containing Enzymes

C. Witmer, G. Witz, K. Cooper, 1992 .

Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines

S. O’Brien, C. Witmer, M. Lambert, 2016, Pediatric blood & cancer.

Peripherally Inserted Central Catheters Lead to a High Risk of Venous Thromboembolism in Children.

Lingyun Ji, S. O’Brien, C. Witmer, 2020, Blood.

Prevention of Recurrent Thrombotic Events in Children with Central Venous Catheter-Associated Venous Thrombosis.

C. Witmer, L. Raffini, Hilary Whitworth, 2021, Blood.

High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.

Charles E. Leonard, R. Hubbard, C. Witmer, 2023, Journal of thrombosis and haemostasis : JTH.

Oral bioavailability of chromium from a specific site.

C. Witmer, S. Shupack, R. Harris, 1991, Environmental health perspectives.

Mutagenicity and disposition of chromium.

C. Witmer, S. Shupack, H. S. Park, 1989, The Science of the total environment.

ABSCESS-FORMING FACTOR(S) PRODUCED BY STAPHYLOCOCCUS AUREUS I

C. Witmer, R. Wise, F. Sweeney, 1963, Journal of Bacteriology.

Metabolic correlates of benzene toxicity.

R. Snyder, C. Witmer, J. Kocsis, 1981, Advances in experimental medicine and biology.

Hematologic abnormalities in Aicardi Goutières Syndrome.

A. Vanderver, J. Shults, K. Sullivan, 2022, Molecular genetics and metabolism.

Nephrotoxicity of the 1:1 acrolein-glutathione adduct in the rat.

C. Witmer, G. Witz, Joseph Horvath, 1992, Toxicology and applied pharmacology.

Some activities of the oxidant chromate.

C. Witmer, S. Shupack, E. Yurkow, 1996, Advances in experimental medicine and biology.

Temporal pattern and reversal of impaired hepatic mono-oxygenases by phenobarbital in rats with developing and established adjuvant disease.

C. Witmer, R. D. Smyth, P. Mathur, 1977, Journal of Pharmacology and Experimental Therapeutics.

The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question

S. O’Brien, J. Panepinto, J. Wolfson, 2022, Blood advances.

The ASH‐ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question

S. O’Brien, J. Panepinto, J. Wolfson, 2021, Pediatric blood & cancer.

Optical and electron paramagnetic resonance studies of partially purified rabbit liver cytochrome P-450.

C. Witmer, P. Krauss, H. Remmer, 1975, Advances in experimental medicine and biology.

Biological reactive intermediates IV. Molecular and cellular effects and their impact on human health. Proceedings of the Fourth International Symposium on Biological Reactive Intermediates. January 14-17, 1990, Tucson, Arizona.

C. Witmer, 1991, Advances in experimental medicine and biology.

Biological Reactive Intermediates V

I. Cohen, S. Zderic, H. Greim, 1996, Advances in Experimental Medicine and Biology.

Recurrence of a high‐titre factor VIII inhibitor in a haemophilia A patient on emicizumab prophylaxis

C. Witmer, Bhavya S. Doshi, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

ABSCESS-FORMING FACTOR(S) PRODUCED BY STAPHYLOCOCCUS AUREUS II

C. Witmer, R. Wise, F. Sweeney, 1963, Journal of bacteriology.

Primary thromboprophylaxis in hospitalized children: A multi-center retrospective analysis.

C. Witmer, M. Hall, S. Carpenter, 2019, Thrombosis research.

Urinary metabolites of benzene in the mouse.

R. Snyder, C. Witmer, J. Kocsis, 1981, Advances in experimental medicine and biology.

Mixed function oxidase enzyme responses to in vivo and in vitro chromate treatment.

C. Witmer, E. Faria, 1991, Advances in experimental medicine and biology.

Behcet Disease Initially Presenting as Deep Venous Thrombosis: A Case Report.

C. Witmer, K. Chikwava, A. Desai, 2017, Journal of pediatric hematology/oncology.